Eplerenone reduces morbidity, mortality after acute MI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1382, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reviparin reduces reinfarction, mortality after MI

By  

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Pexelizumab: reduced mortality rate after acute MI

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Inappropriate -blocker prescribing after acute myocardial infarction (MI) is associated with greater mortality than appropriate prescribing

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Alteplase reduces TFPI-1 activity in acute MI

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Sertraline for depression after acute MI

By  

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite